Cargando…

Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods

INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-langu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Merina, Vajaranant, Thasarat S., Aref, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675727/
https://www.ncbi.nlm.nih.gov/pubmed/26253854
http://dx.doi.org/10.1007/s40123-015-0037-z
_version_ 1782405049401475072
author Thomas, Merina
Vajaranant, Thasarat S.
Aref, Ahmad A.
author_facet Thomas, Merina
Vajaranant, Thasarat S.
Aref, Ahmad A.
author_sort Thomas, Merina
collection PubMed
description INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-language literature was conducted by performing a broad search of PubMed from 1972 through 2015 using the keywords hypotony maculopathy and hypotony. Additional articles were identified from bibliographies of relevant articles. RESULTS: Hypotony maculopathy was infrequent before the introduction of antimetabolite agents in glaucoma-filtering surgery, and the incidence of this entity is now up to 20%. Risk factors for developing hypotony maculopathy include male gender, young age, myopia, and primary filtering surgery. Correctly identifying the etiology of hypotony is essential for successful treatment. Treatment of hypotony maculopathy includes procedures to elevate the intraocular pressure, thus reversing the collapse of the scleral wall and chorioretinal wrinkling. CONCLUSION: This review discusses the definition, clinical presentation, pathophysiology, incidence and risk factors, prevention and treatment of hypotony maculopathy.
format Online
Article
Text
id pubmed-4675727
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-46757272015-12-18 Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods Thomas, Merina Vajaranant, Thasarat S. Aref, Ahmad A. Ophthalmol Ther Review INTRODUCTION: Hypotony maculopathy is ocular hypotony complicated by papilledema and/or folding of the retina and choroid in the posterior pole. Our objective was to examine the current literature regarding hypotony maculopathy and treatment methods. METHODS: A systematic review of the English-language literature was conducted by performing a broad search of PubMed from 1972 through 2015 using the keywords hypotony maculopathy and hypotony. Additional articles were identified from bibliographies of relevant articles. RESULTS: Hypotony maculopathy was infrequent before the introduction of antimetabolite agents in glaucoma-filtering surgery, and the incidence of this entity is now up to 20%. Risk factors for developing hypotony maculopathy include male gender, young age, myopia, and primary filtering surgery. Correctly identifying the etiology of hypotony is essential for successful treatment. Treatment of hypotony maculopathy includes procedures to elevate the intraocular pressure, thus reversing the collapse of the scleral wall and chorioretinal wrinkling. CONCLUSION: This review discusses the definition, clinical presentation, pathophysiology, incidence and risk factors, prevention and treatment of hypotony maculopathy. Springer Healthcare 2015-08-08 2015-12 /pmc/articles/PMC4675727/ /pubmed/26253854 http://dx.doi.org/10.1007/s40123-015-0037-z Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Thomas, Merina
Vajaranant, Thasarat S.
Aref, Ahmad A.
Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title_full Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title_fullStr Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title_full_unstemmed Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title_short Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods
title_sort hypotony maculopathy: clinical presentation and therapeutic methods
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675727/
https://www.ncbi.nlm.nih.gov/pubmed/26253854
http://dx.doi.org/10.1007/s40123-015-0037-z
work_keys_str_mv AT thomasmerina hypotonymaculopathyclinicalpresentationandtherapeuticmethods
AT vajaranantthasarats hypotonymaculopathyclinicalpresentationandtherapeuticmethods
AT arefahmada hypotonymaculopathyclinicalpresentationandtherapeuticmethods